More Data Needed for Neoadjuvant Tx for Bile Duct Cancer : v

In a debate held recently on the use of neoadjuvant therapy for high-risk intrahepatic cholangiocarcinoma, both sides agreed that more research is needed.

Related Keywords

Massachusetts , United States , Houston , Texas , Boston , California , American , Cristinar Ferrone , Los Angeles , S Tran Cao , Motaz Qadan , Tran Cao , International Conference Of Surgical Cancer Care , University Of Texas Md Anderson Cancer Center , American Cancer Society , American Society For Clinical Oncology , International Conference , Surgical Cancer Care , Cancer Center , American Cancer , American Society , Gapontsev Family Endowed Chair , Massachusetts General Hospital , Medscape Medical , Drugs Become Obsolete , Noncolorectal Gastrointestinal Cancer , Oncolorectal Gi Cancer , Neoadjuvant , Hepatocellular Carcinoma , Liver Cancer , Dcc , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Cancer , Alignant Neoplasia , Arcinoma , Toxicology , Surgery , Oncological Surgery , Pancreatic Surgery , Biliary Tract , Cholangiocarcinoma , Obile , Chemotherapy , Tumor , Patient Safety , Clinical Research , Clinical Trials , Linical Stu ,